Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2024-10-02 00:00:00 ET · period of report 2024-10-01 · accession 0001334549-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-02 | 2024-10-01 | LSTA | Mazzo David J | Pres, CEO, Dir | A - Grant | $2.93 | +58.0K | 238.8K | +32% | +$169.9K | |
| 2024-10-02 | 2024-10-01 | LSTA | Mazzo David J | Pres, CEO, Dir | F - Tax | $2.93 | -27.0K | 211.8K | -11% | -$79.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-01 | A | A | 58,000 | $2.93 | 238,798 | D | — | — | (F1) Reflects 58,000 in performance-based stock units, the criteria for which was satisfied on October 1, 2024 and which vested in full on that same day. (F2) Includes 107,183 unvested restricted stock. |
| 2 | Common | Common Stock | 2024-10-01 | F | D | 26,964 | $2.93 | 211,834 | D | — | — | (F3) Shares withheld as payment of a tax liability on vesting of performance-based stock units. (F2) Includes 107,183 unvested restricted stock. |